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The data is related to the research article entitled “Hypomyeli-
nating leukodystrophy-associated missense mutation in HSPD1
blunts mitochondrial dynamics” [1]. In addition to hypomyelinat-
ing leukodystrophy (HLD) 4 (OMIM no. 612233), it is known that
spastic paraplegia (SPG) 13 (OMIM no. 605280) is caused by
HSPD1’s amino acid mutation. Two amino acid mutations Val-98-
to-Ile (V98I) and Gln-461-to-Glu (Q461E) are associated with
SPG13 [2]. In order to investigate the effects of HSPD1’s V98I or
Q461E mutant on mitochondrial morphological changes, we
transfected each of the respective mutant-encoding genes into
Cos-7 cells. Either of V98I or Q461E mutant exhibited increased
number of mitochondria and short length mitochondrial
morphologies. Using MitoTracker dye-incorporating assay,
decreased mitochondrial membrane potential was also observed in
both cases. The data described here supports that SPG13-
associated HSPD1 mutant participates in causing aberrant mito-
chondrial morphological changes with decreased activities.
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areaCell biology, Biochemistryype of data Figure
ow data was
acquiredCytochemistryata format Raw and analyzed data
xperimental factors Mitochondrial morphologies in SPG13-associated HSPD1 mutant-
introduced Cos-7 cells
xperimental features Fluorescent and confocal microscopic analysis
ata source location National Research Institute for Child Health and Development, Tokyo,
Japan
ata accessibility Data is available with this studyDValue of the data Disease-associated HSPD1 mutant-expressing mitochondria exhibited short length morphologies.
 Disease-associated HSPD1 mutant-expressing mitochondria increased their number in cells.
 Disease-associated HSPD1 mutant-expressing mitochondria exhibit their decreased membrane
potential in MitoTracker dye-incorporating assay.1. Data, experimental design, materials and methods
1.1. Experimental design
To explore how spastic paraplegia (SPG13)-associated mutant of HSPD1 has an effect on mito-
chondrial morphology, we set out to study transfection experiments using Cos-7 cells. Since this cell
line has large cytoplasmic regions, it is suitable to observe morphological changes of mitochondria
[1].
1.2. Plasmid constructs
Gene recombinations were carried out in accordance with a protocol approved by the Japanese
National Research Institute for Child Health and Development Gene Recombination Committee. The
cDNA encoding HSPD1 was ampliﬁed from total human brain cDNAs (NipponGene, Tokyo, Japan). The
cDNA encoding SPG13-associated Val-98-to-Ile (V98I) or Gln-461-to-Glu (Q461E) mutant of HSPD1
[2] was produced by the method of overlapping PCR. They were ligated into the BamHI multiple
cloning site (MCS) of the mammalian expression vector pTagGFP (Evrogen, Moscow, Russia). As the
result, their plasmids encoded fusion proteins possessing six amino acids in MCS plus TagGFP in the
C-terminus of HSPD1 protein. DNA sequences were conﬁrmed by Fasmac (Kanagawa, Japan). The
pTagRFP-Mito (mitochondrially-localized RFP) plasmid was purchased from Evrogen. TagGFP and
TagRFP are monomeric green and red ﬂuorescent proteins, respectively.
1.3. Cell culture and transfection
Monkey kidney Cos-7 cells (Human Science BioResource Bank, Tokyo, Japan) were cultured on cell
culture dishes (Greiner Bio-One, Oberösterreich, Germany) in DMEM containing 10% heat-inactivated
FBS and PenStrep (Thermo Fisher Scientiﬁc, Waltham, MA, USA) in 5% CO2 at 37 °C. Cells were
Fig. 1. Mitochondria harboring HSPD1 (V98I) exhibit short length phenotypes. Cells were transfected with the pTagRFP-
mitochondrion-localized Mito plasmid (red ﬂuorescence) together with the pTagGFP-wild type (WT) HSPD1 or pTagGFP-
HSPD1 (V98I) (green ﬂuorescence) plasmid. The merged photograph (yellow ﬂuorescence) and the high magniﬁcation image
indicated by white square are shown. The length of mitochondria is also shown in the graph (**, po0.05; n¼70 mitochondria
from 3 cells of the respective independent experiments).
Fig. 2. Mitochondria harboring HSPD1 (Q461E) exhibit short length phenotypes. Cells were transfected with the pTagRFP-Mito
plasmid (red ﬂuorescence) together with the pTagGFP-wild type (WT) HSPD1 or pTagGFP-HSPD1 (Q461E) plasmid (green
ﬂuorescence). The merged photograph (yellow ﬂuorescence) and the high magniﬁcation image indicated by white square are
shown. The length of mitochondria is also shown in the graph (**, po0.05; n¼70 mitochondria from 3 cells of the respective
independent experiments).
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Fig. 3. The number of mitochondria harboring HSPD1 (V98I) is greater than that of mitochondria harboring wild type HSPD1.
Cells were transfected with the empty vector pTagRFP (red ﬂuorescence), to mark whole cytoplasmic regions, together with the
plasmid encoding wild type (WT) HSPD1 or HSPD1 (V98I) (green ﬂuorescence). The number of mitochondria is also shown in
the graph (**, po0.05; n¼12 cells from 3 independent experiments).
Fig. 4. The number of mitochondria harboring HSPD1 (Q461E) is greater than that of mitochondria harboring wild type HSPD1.
Cells were transfected with the empty vector pTagRFP (red ﬂuorescence) together with the plasmid encoding wild type (WT)
HSPD1 or HSPD1 (V98I) (green ﬂuorescence). The number of mitochondria is also shown in the graph (**, po0.05; n¼12 cells
from 3 independent experiments).
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Fig. 5. Mitochondria harboring HSPD1 (V98I) decrease MitoTracker Red CM-H2Xros dye-incorporating activity. Cells were
transfected with the plasmid encoding wild type (WT) HSPD1 or HSPD1 (V98I) (green ﬂuorescence) and were incubated with
MitoTracker Red CM-H2Xros dye incorporated into active mitochondria (red ﬂuorescence). The percentage of dye-incorporated
mitochondria is shown in the graph (**, po0.05; n¼12 cells from 3 independent experiments).
Fig. 6. Mitochondria harboring HSPD1 (Q461E) decrease MitoTracker Red CM-H2Xros dye-incorporating activity. Cells were
transfected with the plasmid encoding wild type (WT) HSPD1 or HSPD1 (V98I) (green ﬂuorescence) and were incubated with
MitoTracker Red CM-H2Xros dye incorporated into active mitochondria (red ﬂuorescence). The percentage of dye-incorporated
mitochondria is shown in the graph (**, po0.05; n¼12 cells from 3 independent experiments).
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Y. Miyamoto et al. / Data in Brief 6 (2016) 482–488 487transfected with plasmids using a Lipofectamine LTX Plus transfection kit (Thermo Fisher Scientiﬁc)
or a CalPhos transfection kit (Takara Bio, Kyoto, Japan) according to the respective manufacturers’
instructions. The medium was replaced 4 h after transfection for the lipofection method or 18 h after
transfection for the calcium phosphate method and transfected cells were used for experiments 48 h
after transfection [3,4].
1.4. Cytochemical studies
Before experiments, cells were treated with or without MitoTracker Red CM-H2Xros dye (Thermo
Fisher Scientiﬁc). MitoTracker red ﬂuorescent dye is accumulated in active mitochondria depending
upon their membrane potential. Following culture medium removal, cells were immediately ﬁxed
using an Image-iT Fixation/Permeabilization kit (Thermo Fisher Scientiﬁc). The coverslips were
mounted onto slides with Vectashield reagent (Vector Laboratories, Burlingame, CA, USA) for
observation using confocal microscopy. The confocal images were collected using an IX81 microscope
with a laser-scanning FV500 or FV1000 system (Olympus, Tokyo, Japan) and analyzed using FluoView
software (Olympus) [3,4]. In MitoTracker dye-incorporating assay, the respective pixel values of the
mitochondrion-speciﬁc HSPD1’s green color and the yellow color merged with MitoTracker red
ﬂuorescent dye were measured using ImageJ software. The percentage of a merged yellow color value
per a green color value was considered as that of MitoTracker dye-incorporating mitochondria. The
length of mitochondria harboring HSPD1 (V98I) was shorter than that of mitochondria harboring wild
type HSPD1 by 30% (Fig. 1). Similar data was observed in HSPD1 (Q461E) (Fig. 2). As the result, the
number of mitochondria harboring HSPD1 (V98I) or HSPD1 (Q461E) was 1.5-fold greater than that
of mitochondria harboring wild type HSPD1 and is depicted in Figs. 3 and 4, respectively. Mito-
chondria harboring wild type HSPD1 had the ability to incorporate a typical quantity of MitoTracker
dye. In contrast, HSPD1 (V98I) or HSPD1 (Q461E) decreased dye-incorporating activity by 50%
(Figs. 5 and 6).
1.5. Statistical analysis
The values shown in the ﬁgure panels represent the means7standard deviation from separate
experiments. Comparisons between two experimental groups were made using the unpaired Stu-
dent’s t test (**, po0.05). p Values less than 0.05 were considered signiﬁcant.Conﬂict of interest
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